Shrestha M, Chiu M J, Martin R L, Cush J J, Wainscott M S
Division of Emergency Medicine, University of Texas Southwestern Medical School.
Am J Emerg Med. 1994 Jul;12(4):454-5. doi: 10.1016/0735-6757(94)90061-2.
Nine consecutive patients presenting with acute gouty arthritis were treated with ketorolac 60 mg intramuscularly (IM). The average age was 58. Seven were male, and six were black. Pain was quantified in 6 of the patients using a 10-cm visual analog scale that the patients completed before and 30, 60, and 90 minutes after ketorolac administration. The mean pain score (+/- standard error of the mean) dropped from 6.43 (+/- 1.25), out of a possible 10, to 1.01 (+/- 35) (P < .01). There were no side effects of the medication. All of the patients were able to leave the treatment area satisfied with their treatment. None of the patients required crutches at discharge.
连续九名急性痛风性关节炎患者接受了60毫克酮咯酸肌肉注射治疗。平均年龄为58岁。七名男性，六名黑人。六名患者使用10厘米视觉模拟量表对疼痛进行量化，患者在酮咯酸给药前以及给药后30、60和90分钟完成量表填写。平均疼痛评分（±平均标准误差）从可能的10分中的6.43（±1.25）降至1.01（±0.35）（P<0.01）。该药物无副作用。所有患者对治疗满意，能够离开治疗区域。出院时没有患者需要拐杖。
